Last Updated on November 1, 2024 by The Health Master

NPPA

Download NPPA notification No. S.O. 4497 (E) dt 14-10-2024, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 20 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 4497(E) dt 14-10-2024 based on the decision of 127th Authority meeting dated 08-10-2024.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:

(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company
Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

S. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (in Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Bisoprolol and Amlodipine Tablet	Each Film Coated Tablet Contains: Bisoprolol Fumarate IP 2.5 mg + Amlodipine Besilate IP eq. to Amlodipine 5 mg	1 Tablet	M/s Swiss Garnier Genexiaa Sciences Pvt. Ltd./ M/s Abbott Healthcare Pvt. Ltd.	6.23
2	Bisoprolol and Amlodipine Tablet	Each Film Coated Tablet Contains: Bisoprolol fumarate IP 5 mg + Amlodipine Besilate IP eq. to Amlodipine 5 mg	1 Tablet	M/s Swiss Garnier Genexiaa Sciences Pvt. Ltd./ M/s Abbott Healthcare Pvt. Ltd.	8.34
3	Gentamicin and Dexamethasone Eye Drops	Composition: Gentamicin 0.3%w/v (as gentamicin sulphate IP 3000units/ml) + Dexamethasone IP 0.1%w/v (as Dexamethasone Sodium phosphate IP) Benzalkonium Chloride IP 0.01%w/v	1 ml	M/s HAB Pharmaceuticals & Research Ltd/ M/s Mankind Prime Labs Pvt Ltd.	2.01
4	Levosalbutamol and Ipratropium Bromide Respules	Each 2.5 ml respule contains: Levosalbutamol Sulphate IP eq. to Levosalbutamol 1.25 mg + Ipratropium Bromide IP eq. to Ipratropium (Anhydrous) 500 mcg	1 ml	M/s Higgs Healthcare/ M/s Mankind Prime Labs Pvt Ltd.	5.75
5	Abacavir, Dolutegravir and Lamivudine Tablet	Each film coated tablet Contains: Abacavir Sulfate USP eq. to Abacavir 600 mg Dolutegravir Sodium eq. to Dolutegravir 50 mg Lamivudine USP 300 mg	1 Tablet	M/s. APL Healthcare Ltd./ M/s Aurobindo Pharma Ltd.	161.10
6	Atorvastatin, Aspirin and Clopidogrel Capsule	Each hard gelatin Capsule Contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg + Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as film coated tablet) + Aspirin IP 75 mg (as enteric coated tablet)	1 Capsule	M/s Surien Pharmaceuticals (P) Ltd./ M/s Unison Pharmaceuticals Pvt. Ltd.	5.27
7	Atorvastatin, Aspirin and Clopidogrel Capsule	Each hard gelatin Capsule Contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg + Atorvastatin Calcium IP eq. to Atorvastatin 10 mg (as film coated tablet) + Aspirin IP 75 mg (as enteric coated tablet)	1 Capsule	M/s Surien Pharmaceuticals (P) Ltd./ M/s Unison Pharmaceuticals Pvt. Ltd.	3.80
8	Cefuroxime Axetil Tablet	Each Film Coated Tablet Contains: Cefuroxime Axetil IP eq to Cefuroxime 250mg	1 Tablet	M/s Innova Captab Ltd/ M/s Dr Reddy’s Laboratories Ltd	26.98
9	L-carnitine L- Tartrate, Mecobalamin and Folic Acid Tablet	Each film coated Tablet Contains: L-Carnitine L-Tartrate eq. to L- carnitine 500 mg Mecobalamin IP 1500 mcg Folic Acid IP 1.5 mg	1 Tablet	M/s J.K. Printpack (Pharma Division)/ M/s Cadila Pharmaceuticals Ltd.	14.50
10	Sitagliptin, Metformin Hydrochloride and Glimepiride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd/ M/s Unison Pharmaceuticals Pvt Ltd	12.19

11	Sitagliptin, Metformin Hydrochloride and Glimepiride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 1mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd/ M/s Unison Pharmaceuticals Pvt Ltd	11.05
12	Sitagliptin, Metformin Hydrochloride and Glimepiride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Medley Pharmaceuticals Ltd	12.19
13	Sitagliptin, Metformin Hydrochloride and Glimepiride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 1mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Medley Pharmaceuticals Ltd	11.05
14	Dapagliflozin, Sitagliptin and Metformin (ER) Tablet	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 500 mg (as Extended Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd/ M/s Primus Remedies Pvt Ltd	16.96
15	Dapagliflozin, Sitagliptin and Metformin (ER) Tablet	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd/ M/s Primus Remedies Pvt Ltd	17.89
16	Bisoprolol and Telmisartan Tablet	Each Film Coated Bilayered Tablet Contains: Bisoprolol Fumarate IP 2.5 mg + Telmisartan IP 40 mg	1 Tablet	M/s Mascot Health Series Pvt Ltd/ M/s Macleods Pharmaceuticals Ltd	9.65
17	Bisoprolol and Telmisartan Tablet	Each Film Coated Bilayered Tablet Contains: Bisoprolol Fumarate IP 5 mg + Telmisartan IP 40 mg	1 Tablet	M/s Mascot Health Series Pvt Ltd/ M/s Macleods Pharmaceuticals Ltd	11.21
18	Esomeprazole and Domperidone (SR) Capsules	Each hard gelatin capsule contains: Esomeprazole Magnesium IP eq. to Esomeprazole 40 mg (as enteric coated pellets) Domperidone Maleate IP eq. to Domperidone 30 mg (Sustained release)	1 Capsule	M/s Windlas Biotech Ltd./ M/s Biological E. Ltd.	5.36
19	Ceftriaxone and Tazobactam	Each vial Contains: Sterile Ceftriaxone Sodium IP eq to Ceftriaxone 250 mg Sterile Tazobactam Sodium IP eq to Tazobactam 31.25mg	1 vial	M/s GMH Organics/ M/s Aurobindo Pharma Ltd	66.92
20	Ceftriaxone and Tazobactam	Each vial Contains: Sterile Ceftriaxone Sodium IP eq to Ceftriaxone 500 mg Sterile Tazobactam Sodium IP eq to Tazobactam 62.5mg	1 vial	M/s GMH Organics/ M/s Aurobindo Pharma Ltd	111.16

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• DCGI and Cosmetics Industry to meet on Regulatory issues
  November 14, 2024
• Significance of Granules Manufacturing in the Pharmaceutical Industry
  November 14, 2024
• 4th International Conference on Pharmaceutical and Healthcare: Lloyd
  November 13, 2024
• USFDA approval granted for Medical Device for heart condition
  November 13, 2024
• Drug recall: Ascorbic Acid Injection recalled due to this reason
  November 13, 2024
• Recommendations for New Rules for Nutraceuticals: FSSAI
  November 13, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: